๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

P300 is unaffected by glucose increase

โœ Scribed by Mark W. Geisler; John Polich


Book ID
119161598
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
840 KB
Volume
37
Category
Article
ISSN
0301-0511

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Amonafide, a topoisomerase II inhibitor,
โœ MyDoanh Chau; Jennifer L. Christensen; Alfred M. Ajami; Robert L. Capizzi ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 392 KB

Over-expression of P-glycoprotein (Pgp+) has been related to resistance to classical Topo II inhibitors used in the treatment of AML and is common in patients with poor-prognosis, such as those with secondary AML (sAML). Since clinical trials with amonafide, a unique ATP-independent Topo II inhibito